A randomized, double-blind comparison of botulinum toxin type A (Botox®) and divalproex sodium (Depakote®) for the prophylactic treatment of migraine headaches:: a pilot study

被引：0
|
作者：
Porter, J [1 ]
机构：
[1] Salem Neurol Ctr, Winston Salem, NC USA
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2005年 / 238卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S490 / S491
页数：2
相关论文
共 50 条
  • [31] Botulinum toxin injection in the treatment of tennis elbow - A double-blind, randomized, controlled, pilot study
    Hayton, MJ
    Santini, AJA
    Hughes, PJ
    Frostick, SP
    Trail, IA
    Stanley, JK
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2005, 87A (03): : 503 - 507
  • [32] Comparison of tiapride and topiramate in the prophylactic treatment of chronic migraine: a randomised,double-blind, pilot study
    Juica-Avello, Sergio
    Riquelme-Vergara, Cesar
    Condeza-Riquelme, Felipe
    Gonzalez-Burboa, Alexis
    Fuentealba-Sandoval, Mario
    Klaassen-Pinto, Gonzalo
    Perez-Villalobos, Christian
    Vera-Calzaretta, Aldo
    Contreras-Espinoza, Loreto
    Werlinger-Estay, Enrique
    Herrera-Hormazabal, Carolina
    REVISTA DE NEUROLOGIA, 2022, 74 (10) : 325 - 330
  • [33] Comparison of botulinum toxin type-A and divalproex sodium for prevention of chronic and episodic migraine
    Chitsaz, Ahmad
    Ghorbani, Abbas
    Hoseinzadeh, Hadi
    Nazari, Fatemeh
    Norouzi, Rasul
    Tajic, Soufi
    NEUROLOGY ASIA, 2012, 17 (02) : 127 - 132
  • [34] A double-blind, randomized, parallel group design comparison of botulinum toxin, type A (Botox®) and botulinum toxin, type B (Myobloc™) on autonomic symptoms and physiology in patients with cervical dystonia
    Tintner, R
    Winzer, UF
    Smalky, KA
    Jankovic, J
    NEUROLOGY, 2004, 62 (07) : A538 - A538
  • [35] Botulinum toxin type A prophylactic treatment for episodic migraine using a modified follow-the-pain treatment paradigm: A randomized, double-blind, placebo controlled, phase II study
    Aurora, SK
    Gawel, M
    Brandes, J
    Pokta, S
    VanDenburgh, AM
    HEADACHE, 2005, 45 (06): : 825 - 826
  • [36] Botulinum toxin type a for the prophylactic treatment of chronic daily headache: A randomized, double-blind, placebo-controlled trial
    Frishberg, BM
    Mathew, NT
    Gawel, M
    Dimitrova, R
    Gibson, J
    Turkel, C
    NEUROLOGY, 2005, 64 (06) : A422 - A422
  • [37] Botulinum toxin type A for the prophylactic treatment of chronic daily headache: A randomized, double-blind, placebo-controlled trial
    Silberstein, SD
    Stark, SR
    Lucas, SM
    Christie, SN
    DeGryse, RE
    Turkel, CC
    MAYO CLINIC PROCEEDINGS, 2005, 80 (09) : 1126 - 1137
  • [38] Efficacy of Botulinum Toxin Type A for the Prophylaxis of Episodic Migraine Headaches: A Meta-analysis of Randomized, Double-Blind, Placebo-Controlled Trials
    Shuhendler, Adam J.
    Lee, Soyoung
    Siu, Michelle
    Ondovcik, Stephanie
    Lam, Kyla
    Alabdullatif, Awatif
    Zhang, Xiaochu
    Machado, Marcio
    Einarson, Thomas R.
    PHARMACOTHERAPY, 2009, 29 (07): : 784 - 791
  • [39] A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches
    Relja, M.
    Poole, A. C.
    Schoenen, J.
    Pascual, J.
    Lei, X.
    Thompson, C.
    CEPHALALGIA, 2007, 27 (06) : 492 - 503
  • [40] Prospective, Randomized, Double-Blind Study, Comparing Botulinum Toxins Type A Botox and Prosigne for Blepharospasm and Hemifacial Spasm Treatment
    Aparecida Barasnevicius Quagliato, Elizabeth Maria
    Carelli, Edmur Franco
    Viana, Maura Aparecida
    CLINICAL NEUROPHARMACOLOGY, 2010, 33 (01) : 27 - 31
12345